Oral "Lantigen B" appoint drops for prevention of recurrent upper respiratory tract infections at some patients medicament can promote reduction of quantity and intensity of cases of infection. To children appoint for prevention of recurrent cases of bacterial upper respiratory tract infections at children with a large number of cases for their age, than it was expected. Drug can reduce quantity and intensity of cases of infection.

Structure

Active ingredient: 1 ml of suspension contains mix of bacterial lysates:

• Staphylococcus aureus 79.6 of the joint-stock company;
• Streptococcus pyogenes of A 126.2 group of the joint-stock company;
• Streptococcus pneumoniae of type 3 63,2 of the joint-stock company;
• Haemophilus influenzae of type B 50.2 of the joint-stock company;
• Branhamella catarrhalis 39.9 of the joint-stock company;
• Klebsiella pneumoniae 39.8 of the joint-stock company;

Excipients: polysorbate 80, sodium methylparahydroxybenzoate (E 219), a chlorhexidina diacetate, water purified.

Contraindication

• Hypersensitivity to active ingredient or to any excipient of drug.
• Autoimmune diseases.
• Acute intestinal infections.

Routes of administration

Adults and children are more senior than 10 years

One dose (15 drops) to Lantigen of B two times a day drip under language (in the morning and in the evening). Necessary quantity of drops receive, having turned a bottle and pressing a cover dropper.

Children aged from 1 up to 10 years

One dose (15 drops) to Lantigen of B drip under language once a day in the morning, it is desirable on an empty stomach, or a half of one dose (7-8 drops) two times a day drip under language (in the morning and in the evening). Necessary quantity of drops receive, having turned a bottle and pressing a cover dropper.

Feature of use

Treatment needs to be stopped in case of fervescence, especially if it arose in an initiation of treatment.

Should avoid simultaneous use with others immunostimulators.

in case of reactions of hypersensitivity use of medicament should be stopped immediately without updating.

Pregnancy

Data on use to Lantigen B by pregnant women are absent therefore it is recommended to avoid inclusion in pregnancy time.

not to apply

to children till 1 year.

Drivers

Data are absent.

Risks of overdose are unknown to

.

Side reactions

After the first use of medicament perhaps temporary deterioration in symptoms, such as constipation, rhinorrhea.

interaction Researches with other medicines were not conducted by

.

Storage conditions

to Store

in original packing at a temperature not above 25 °C in the place protected from light. To store out of children's reach.

Expiration date - 3 years.

After opening of a bottle the expiration date makes no more than 28 days.